ZO-Y49 PhaseIII clinical trial
Latest Information Update: 26 May 2016
At a glance
- Drugs ZO Y49 (Primary)
- Indications Female genital diseases
- Focus Adverse reactions; Therapeutic Use
- Sponsors Zeria
- 26 May 2016 New trial record
Latest Information Update: 26 May 2016